Friday, December 19, 2014 11:35:53 AM
1. I went to the ASHM. Steipp could confirm only two machines: one in RSM and one in Austria at Engel. He could not confirm any other machines at any other locations. As you well know, all machine orders (even those in Europe) must be routed through LQMT RSM (read the Engel website if you don't think so). There is no NDA that prevents Steipp from saying that more machines than the two alluded to above exist. Yet he just couldn't bring himself to fabricate a number in front of the investors.
2. Steipp confirmed the names of the mold makers and manufacturers agents. He did not confirm any contract manufacturers other than VPC.
3. The existence of a contract manufacturer (other than VPC) would mean that the contract manufacturer has customers willing to replace their existing parts made by other methodologies with the Liquidmetal based technology. It would also mean they would have a machine installed and ready to go to meet their customers needs. This benchmark has not been made according to Steipp, otherwise, they would have introduced them at the 3 day presentation of vendors, sales agents and investors.
Simple logic always beats out fanciful fantasies as projected in your post. It's good to consider the inertia of the engineers, purchasing agents and possible customers before positing that an overnight wonder of revenues is going to occur.
Enjoy the sugar plums over the Holidays.
PS. In case you have not noticed, success is measured in revenues and net earnings positive, not in speculative prototypes and chess pieces.
Surely, you must have an answer for the other question. Have at it. You will describe every other poster except one.
Ta Da! (Courtesy of Microsoft)
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM